A Prospective Randomized Study Comparing Different Dilation Durations for Endoscopic Papillary Balloon Dilatation
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Endoscopic papillary balloon dilation is as effective as sphincterotomy in treating bile duct stone. However, a need to switch to sphincterotomy is noted in about 20% of cases receiving dilation for lithotripsy. It is hypothesized that a longer dilation duration (5 min. vs. 1 min.) can decrease the need of switching to sphincterotomy.
| Condition | Intervention |
|---|---|
|
Choledocholithiasis |
Procedure: Endoscopic papillary balloon dilation-5 minutes Procedure: Endoscopic papillary balloon dilation-1 minute |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Double-Blind Primary Purpose: Treatment |
| Official Title: | A Prospective Randomized Multicenter Study Comparing Different Dilation Durations During Endoscopic Papillary Balloon Dilatation for Bile Duct Stones. |
- need of switching to sphincterotomy
- efficacy of lithotripsy
- post-ERCP complications
| Estimated Enrollment: | 160 |
| Study Start Date: | January 2007 |
| Estimated Study Completion Date: | January 2008 |
Endoscopic papillary balloon dilatation (EPBD) has been proposed as an alternative to endoscopic sphincterotomy (EST) for endoscopic treatment of common bile duct (CBD) stones. EPBD is as effective as EST in stone clearance with a lower risk of hemorrhage, and may preserve the function of sphincter of Oddi. However, it has been reported that about 20% of patients undergoing EPBD need EST as a rescue procedure for lithotripsy. A longer dilation duraton of 5 mintues as opposed to 1 minute has been proposed to decrease oozing after dilation and facilitate lithotripsy, and it is hypothesized that it will reduce the need of switching to EST.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients undergoing endoscopic retrograde cholangiopancreatography for choledocholithiasis
Exclusion Criteria:
- Consent not obtained.
- No apparent stone.
- Intradiverticular papilla.
- Prior EST.
- Bile duct stricture.
- Pancreatic or biliary malignant disorders.
- Intrahepatic stones.
- Active acute pancreatitis.
- Sphincter of Oddi dysfunction.
- Pregnancy.
- Primary sclerosing cholangitis or choledochocyst.
- Previous biliary surgery other than cholecystectomy.
- Stone impaction at ampulla.
- Precut for cannulation.
Contacts and Locations| Contact: Wei-Chih Liao, MD | 886-2-23123456 ext 3356 | david.ntuh@msa.hinet.net |
| Taiwan | |
| National Taiwan University Hospital | Recruiting |
| Taipei, Taiwan, 100 | |
| Principal Investigator: Wei-Chih Liao, MD | |
| Principal Investigator: | Wei-Chih Liao, MD | National Taiwan University Hospital |
More Information
Publications:
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| ClinicalTrials.gov Identifier: | NCT00451581 History of Changes |
| Other Study ID Numbers: | 9561709036 |
| Study First Received: | March 22, 2007 |
| Last Updated: | March 22, 2007 |
| Health Authority: | Taiwan: Department of Health |
Keywords provided by National Taiwan University Hospital:
|
Endoscopic papillary balloon dilatation Endoscopic sphincterotomy Choledocholithiasis Efficacy Complication |
Additional relevant MeSH terms:
|
Dilatation, Pathologic Choledocholithiasis Pathological Conditions, Anatomical Common Bile Duct Diseases |
Bile Duct Diseases Biliary Tract Diseases Digestive System Diseases Cholelithiasis |
ClinicalTrials.gov processed this record on May 16, 2013